Truist Securities Reiterates Buy on Merck & Co, Raises Price Target to $142

Merck & Co., Inc. +0.81%

Merck & Co., Inc.

MRK

130.72

+0.81%

Truist Securities analyst Robyn Karnauskas reiterates Merck & Co (NYSE: MRK) with a Buy and raises the price target from $139 to $142.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via